Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit.

Background: Maintaining glucose in the target range, while avoiding hypoglycemia, is challenging in critically ill patients. We investigated the performance and safety of Medtronic Sentrino, a newly developed continuous glucose management (CGM) system for critically ill adults.

Methods: This was a prospective, single-center, single-arm, open-label study in adult patients with cardiac ICU admission.